{"id":920,"date":"2025-06-04T01:57:22","date_gmt":"2025-06-04T08:57:22","guid":{"rendered":"https:\/\/cloudbreakpharma.com\/?p=920"},"modified":"2025-06-04T02:01:33","modified_gmt":"2025-06-04T09:01:33","slug":"cloudbreak-pharmas-global-innovative-ophthalmic-pipeline-cbt-001-completes-the-enrollment-of-all-patients-in-the-international-multi-center-phase-iii-clinical-trial","status":"publish","type":"post","link":"https:\/\/cloudbreakpharma.com\/zh_hk\/cloudbreak-pharmas-global-innovative-ophthalmic-pipeline-cbt-001-completes-the-enrollment-of-all-patients-in-the-international-multi-center-phase-iii-clinical-trial\/","title":{"rendered":"\u64a5\u5eb7\u8996\u96f2\u5168\u7403\u5275\u65b0\u773c\u79d1\u85e5\u7269CBT-001\u570b\u969b\u591a\u4e2d\u5fc3III\u671f\u81e8\u5e8a\u8a66\u9a57\u5b8c\u6210\u5168\u90e8\u60a3\u8005\u5165\u7d44"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"920\" class=\"elementor elementor-920\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c3fe21d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c3fe21d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-74f661f\" data-id=\"74f661f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-cf824e5 elementor-widget elementor-widget-text-editor\" data-id=\"cf824e5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Cloudbreak Pharma Inc.\uff08\u64a5\u5eb7\u8996\u96f2\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u6211\u5011\u7ba1\u7dda\u4e2d\u7528\u65bc\u6cbb\u7642\u7ffc\u72c0\u80ec\u8089\u7684\u5168\u7403\u5275\u65b0\u773c\u79d1\u85e5\u7269CBT-001\u958b\u5c55\u7684\u570b\u969b\u591a\u4e2d\u5fc3III\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u8fd1\u65e5\u5b8c\u6210\u4e86\u5168\u7403\u4e2d\u5fc3\u5168\u90e8\u60a3\u8005\u5165\u7d44\u3002\u8a72\u7814\u7a76\u662f\u4e00\u9805\u96a8\u6a5f\u3001\u96d9\u76f2\u3001\u5b89\u6170\u5291\u5e73\u884c\u5c0d\u7167\u7684III\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u64ec\u5165\u7d44660\u4f8b12\u5468\u6b72\u53ca\u4ee5\u4e0a\u7684\u7ffc\u72c0\u80ec\u8089\u4f34\u7d50\u819c\u5145\u8840\u60a3\u8005\uff0c\u65e8\u5728\u8a55\u4f30CBT-001\u6ef4\u773c\u6db2\u5728\u6e1b\u5c11\u7d50\u819c\u5145\u8840\u548c\u9810\u9632\u7ffc\u72c0\u80ec\u8089\u9032\u5c55\u65b9\u9762\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002<\/p><p>CBT-001\u7531Cloudbreak Pharma Inc.\uff08\u64a5\u5eb7\u8996\u96f2\uff09\u958b\u767c\uff0c\u662f\u5df2\u4e0a\u5e02\u6cbb\u7642\u80ba\u7e96\u7dad\u5316\u85e5\u7269OFEV\u7684\u4e3b\u8981\u6210\u5206\u5c3c\u9054\u5c3c\u5e03\u7684\u5275\u65b0\u6539\u826f\u7522\u54c1\uff0c\u5c0d\u65b0\u751f\u8840\u7ba1\u751f\u6210\u548c\u7d44\u7e54\u7e96\u7dad\u5316\u5747\u6709\u6291\u5236\u4f5c\u7528\u3002\u6b64\u524d\u5df2\u5728\u7f8e\u570b\u5b8c\u6210II\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5b89\u5168\u6027\u9ad8\uff0c\u5177\u6709\u81e8\u5e8a\u7642\u6548\uff0c\u53ef\u6291\u5236\u7ffc\u72c0\u80ec\u8089\u751f\u9577\u4e26\u63a7\u5236\u75c5\u60c5\u9032\u5c55\u3002\u53ef\u7528\u65bc\u7ffc\u72c0\u80ec\u8089\u8f15\u4e2d\u91cd\u5ea6\u5404\u968e\u6bb5\uff0c\u53ca\u624b\u8853\u5f8c\u9632\u6b62\u5fa9\u767c\u3002\u9060\u5927\u96c6\u5718\u64c1\u6709CBT-001\u5728\u4e2d\u570b\u5927\u9678\u3001\u4e2d\u570b\u9999\u6e2f\u7279\u5225\u884c\u653f\u5340\u3001\u4e2d\u570b\u6fb3\u9580\u7279\u5225\u884c\u653f\u5340\u3001\u53ca\u4e2d\u570b\u81fa\u7063\u5730\u5340\u7684\u7368\u5bb6\u751f\u7522(\u542b\u6280\u8853\u8f49\u79fb)\u53ca\u5546\u696d\u5316\u6b0a\u5229\uff0c\u6388\u6b0a\u7bc4\u570d\u6db5\u84cbCBT-001\u7684\u5728\u7814\u9069\u61c9\u75c7\uff0c\u5373\u9810\u9632\u7ffc\u72c0\u80ec\u8089\u751f\u9577\u53ca\u6e1b\u5c11\u7d50\u819c\u5145\u8840\u3002\u64a5\u5eb7\u8996\u96f2\u4ea6\u5c07CBT-001\u6388\u6b0a\u65bc\u53c3\u5929\u88fd\u85e5\uff0c\u8a72\u6388\u6b0a\u6d89\u53ca\u65e5\u672c\u53ca\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u548c\u5370\u5c3c\u5728\u5167\u7684\u6771\u5357\u4e9e\u5730\u5340\u3002\u6839\u64da\u5354\u5b9a\u689d\u6b3e\uff0c\u64a5\u5eb7\u8996\u96f2\u6388\u6b0a\u53c3\u5929\u88fd\u85e5\u5728\u8a72\u5730\u5340\u958b\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316CBT-001\u85e5\u54c1\u3002<\/p><p>\u7ffc\u72c0\u80ec\u8089\u662f\u4e00\u7a2e\u5e38\u898b\u7684\u6162\u6027\u708e\u75c7\u589e\u751f\u6027\u773c\u8868\u75be\u75c5\uff0c\u901a\u5e38\u767c\u751f\u65bc\u773c\u89d2\u90e8\u7d50\u819c\uff0c\u9010\u6f38\u4fb5\u8972\u81f3\u89d2\u819c\uff0c\u5f15\u8d77\u6563\u5149\u6216\u906e\u64cb\u77b3\u5b54\uff0c\u5f9e\u800c\u5c0e\u81f4\u8996\u529b\u4e0b\u964d\u751a\u81f3\u81f4\u76f2\u3002\u64da\u4e16\u754c\u885b\u751f\u7d44\u7e54\u767c\u4f48\u7684\u300a\u4e16\u754c\u8996\u89ba\u5831\u544a\u300b\u6240\u793a\uff0c\u7ffc\u72c0\u80ec\u8089\u7684\u5168\u7403\u60a3\u75c5\u7387\u70ba10.2%\uff0c\u4e2d\u570b\u8fb2\u6751\u5730\u5340\u9ad8\u905433%\u3002\u6839\u64da\u76f8\u95dc\u6587\u737b\uff0c\u4e2d\u570b40\u6b72\u53ca\u4ee5\u4e0a\u4eba\u7fa4\u60a3\u75c5\u7387\u70ba13.4%\uff0c\u4e14\u96a8\u8457\u5e74\u9f61\u589e\u9577\u800c\u4e0d\u65b7\u5347\u9ad8\u3002\u76ee\u524d\u4e26\u6c92\u6709\u6cbb\u7642\u7ffc\u72c0\u80ec\u8089\u7684\u5c08\u9580\u85e5\u7269\uff0c\u81e8\u5e8a\u4ee5\u4eba\u5de5\u6dda\u6db2\u3001\u975e\u753e\u9ad4\u985e\u3001\u7cd6\u76ae\u8cea\u6fc0\u7d20\u6ef4\u773c\u6db2\u7b49\u6a19\u7c64\u5916\u7528\u85e5\u70ba\u4e3b\uff0c\u4f46\u73fe\u6709\u7684\u6cbb\u7642\u85e5\u7269\u672a\u986f\u793a\u78ba\u5207\u7642\u6548\u4e14\u5b58\u5728\u9577\u671f\u7528\u85e5\u5b89\u5168\u6027\u98a8\u96aa\u554f\u984c\u3002\u56b4\u91cd\u60a3\u8005\u53ef\u901a\u904e\u624b\u8853\u6cbb\u7642\uff0c\u4f46\u7ffc\u72c0\u80ec\u8089\u63a1\u7528\u978f\u819c\u5207\u9664\u8853\u5f8c\uff0c\u8853\u5f8c\u5fa9\u767c\u7387\u70ba30-80%\uff0c\u591a\u6b21\u5fa9\u767c\u53ef\u9020\u6210\u77bc\u7403\u7c98\u9023\uff0c\u5f71\u97ff\u773c\u7403\u904b\u52d5\u3002\u53ef\u898b\uff0c\u5c0d\u7ffc\u72c0\u80ec\u8089\u7684\u6cbb\u7642\u4ecd\u6709\u5de8\u5927\u7684\u81e8\u5e8a\u9700\u6c42\u672a\u7372\u6eff\u8db3\u3002<\/p><p>\u96a8\u8457III\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u60a3\u8005\u5165\u7d44\u7684\u5be6\u73fe\uff0cCBT-001\u5411\u8457\u6210\u70ba\u5168\u7403\u9996\u500b\u7ffc\u72c0\u80ec\u8089\u5c08\u9580\u6cbb\u7642\u85e5\u7269\u7684\u76ee\u6a19\u9081\u51fa\u4e86\u95dc\u9375\u4e00\u6b65\u3002\u64a5\u5eb7\u8996\u96f2\u5c07\u7e7c\u7e8c\u5bc6\u5207\u95dc\u6ce8\u8a66\u9a57\u9032\u5c55\uff0c\u78ba\u4fdd\u7814\u7a76\u7684\u9806\u5229\u63a8\u9032\u3002\u6211\u5011\u671f\u5f85\u9019\u9805\u5275\u65b0\u7642\u6cd5\u80fd\u5920\u65e9\u65e5\u5b8c\u6210\u81e8\u5e8a\u8a66\u9a57\uff0c\u70ba\u5168\u7403\u6578\u5104\u7ffc\u72c0\u80ec\u8089\u60a3\u8005\u5e36\u4f86\u5b89\u5168\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\uff0c\u586b\u88dc\u9019\u4e00\u91cd\u8981\u91ab\u7642\u9818\u57df\u7684\u7a7a\u767d\u3002\u540c\u6642\uff0c\u901a\u904e\u8207\u9060\u5927\u96c6\u5718\u548c\u53c3\u5929\u88fd\u85e5\u7684\u6230\u7565\u5408\u4f5c\uff0c\u6211\u5011\u6709\u4fe1\u5fc3\u5c07\u9019\u4e00\u5275\u65b0\u6210\u679c\u60e0\u53ca\u4e9e\u592a\u5730\u5340\u5ee3\u5927\u60a3\u8005\uff0c\u70ba\u6539\u5584\u5168\u7403\u773c\u5065\u5eb7\u505a\u51fa\u7a4d\u6975\u8ca2\u737b\u3002<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Cloudbreak Pharma Inc. is pleased to announce that our pipeline CBT-001, the global innovative ophthalmic drug for the treatment of pterygium has recently completed the enrollment of all patients in global centers in its international multicenter Phase III clinical trial. This study is a randomized, double-blind, placebo-controlled Phase III clinical trial, planning to enroll 660 [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts\/920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/comments?post=920"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts\/920\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media\/736"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media?parent=920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/categories?post=920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/tags?post=920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}